Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)

NCT07439133 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease(CAD)

Interventions

DRUG: XTR004

Sponsor

Sinotau Pharmaceutical Group